CA Stock MarketDetailed Quotes

BBM Blueberries Medical Corp

Watchlist
  • 0.010
  • -0.010-50.00%
15min DelayMarket Closed Jun 28 12:38 ET
3.99MMarket Cap-1111P/E (TTM)

Blueberries Medical Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
53.56%-212.89K
9.26%-1.33M
6.69%-208.6K
24.23%-171.64K
8.18%-493.92K
4.62%-458.39K
12.60%-1.47M
56.09%-223.56K
48.21%-226.52K
-2.30%-537.9K
Net income from continuing operations
41.44%-257.96K
-11.41%-1.64M
-5,825.86%-378.25K
-5.52%-323.37K
3.60%-493.27K
32.88%-440.48K
71.48%-1.47M
100.17%6.61K
28.50%-306.46K
-90.18%-511.72K
Operating gains losses
----
86.19%-75.15K
76.37%-93.54K
78.66%-28.17K
----
----
-44.65%-544.04K
-16.80%-395.87K
-90.93%-132.01K
-1,652.73%-42.35K
Depreciation and amortization
91.75%26.95K
-49.47%149.74K
481.81%34.97K
-27.19%99.7K
-98.79%1.02K
-83.40%14.06K
-64.23%296.33K
-104.64%-9.16K
-49.83%136.93K
-40.60%83.87K
Asset impairment expenditure
----
--180.64K
----
----
----
----
--0
----
----
----
Remuneration paid in stock
----
160.60%20.78K
----
----
----
----
-176.20%-34.3K
----
----
----
Remuneration paid in stock
-24.35%15.65K
-16.45%111.45K
99.42%60.26K
-58.65%13.03K
-35.77%17.46K
-53.47%20.69K
139.28%133.4K
-40.03%30.22K
131.99%31.52K
110.44%27.18K
Other non cashItems
-83.05%20.21K
14.37%263.84K
130.21%13.08K
-84.72%17.56K
47.77%113.93K
45.43%119.27K
-20.98%230.7K
-177.08%-43.3K
44.11%114.89K
-0.67%77.1K
Change In working capital
89.67%-17.75K
-321.08%-348.47K
-120.94%-46.55K
169.50%49.61K
-4.43%-179.61K
-178.99%-171.92K
77.72%-82.76K
558.09%222.24K
63.15%-71.39K
19.20%-171.99K
-Change in receivables
56.23%-26.1K
----
----
67.97%-29.64K
-97.41%-154.34K
-57,243.27%-59.64K
-127.75%-19.74K
326.98%151.09K
4.05%-92.54K
-231.69%-78.18K
-Change in inventory
89.16%-5.01K
----
----
10.13%-15.95K
---90.3K
---46.19K
---12.31K
-93.34%5.43K
69.69%-17.74K
--0
-Change in prepaid assets
-25.50%-60.94K
----
----
158.34%52.45K
-72.09%-19.17K
-113.16%-48.56K
-63.36%-21.53K
-153.35%-7.91K
-16.32%20.3K
-162.77%-11.14K
-Change in payables and accrued expense
763.12%80.97K
----
----
515.46%42.03K
213.91%98.53K
56.37%-12.21K
93.05%-30.17K
141.45%77.49K
130.71%6.83K
60.34%-86.5K
-Change in other working capital
-25.32%-6.67K
----
----
-93.87%721
-473.30%-14.33K
50.47%-5.32K
-78.95%1K
-158.05%-3.86K
124.56%11.77K
107.06%3.84K
Cash from discontinued investing activities
Operating cash flow
53.56%-212.89K
9.26%-1.33M
6.70%-208.6K
24.23%-171.64K
8.18%-493.92K
4.62%-458.39K
12.60%-1.47M
56.09%-223.56K
48.21%-226.52K
-2.30%-537.9K
Investing cash flow
Cash flow from continuing investing activities
0
275.63%382.92K
1,662.40%140.62K
19.53K
103.36%225.61K
-2.83K
309.01%101.94K
-273.29%-9K
0
1,705.02%110.94K
Net PPE purchase and sale
--0
275.63%382.92K
1,662.40%140.62K
--19.53K
103.36%225.61K
---2.83K
1,168.54%101.94K
-1,955.67%-9K
--0
--110.94K
Cash from discontinued investing activities
Investing cash flow
--0
275.63%382.92K
1,662.40%140.62K
--19.53K
103.36%225.61K
---2.83K
309.01%101.94K
-273.29%-9K
--0
1,705.02%110.94K
Financing cash flow
Cash flow from continuing financing activities
97.29%-498
-59.96%539.1K
-58.92%582.57K
69.30%-13.08K
-429.01%-12.01K
44.26%-18.38K
-51.32%1.35M
5,351.62%1.42M
-102.24%-42.62K
103.78%3.65K
Net issuance payments of debt
97.29%-498
-1,093.38%-1.44M
-2,556.75%-1.4M
66.33%-13.08K
-429.01%-12.01K
44.26%-18.38K
12.56%-120.83K
-94.92%-52.64K
-27.50%-38.86K
111.92%3.65K
Net common stock issuance
----
35.03%1.98M
----
----
----
----
-48.30%1.47M
----
----
----
Cash from discontinued financing activities
Financing cash flow
97.29%-498
-59.96%539.1K
-58.92%582.57K
69.30%-13.08K
-429.01%-12.01K
44.26%-18.38K
-51.32%1.35M
5,351.62%1.42M
-102.24%-42.62K
111.92%3.65K
Net cash flow
Beginning cash position
-42.09%818.16K
5.18%1.41M
400.21%594.26K
69.32%790.95K
5.90%907.27K
5.18%1.41M
338.21%1.34M
-93.48%118.8K
16.14%467.13K
-13.54%856.7K
Current changes in cash
55.51%-213.39K
-1,916.64%-410.53K
-56.60%514.59K
38.62%-165.19K
33.78%-280.33K
6.61%-479.6K
-101.96%-20.36K
320.16%1.19M
-118.69%-269.14K
24.85%-423.32K
Effect of exchange rate changes
190.32%23.39K
-304.58%-184.08K
-368.35%-290.69K
60.22%-31.5K
386.03%164.01K
-195.53%-25.89K
--89.98K
81.16%108.33K
-282.70%-79.19K
233.24%33.74K
End cash Position
-30.76%628.16K
-42.09%818.16K
-42.09%818.16K
400.21%594.26K
69.32%790.95K
5.90%907.27K
5.18%1.41M
5.18%1.41M
-93.48%118.8K
16.14%467.13K
Free cash from
53.84%-212.89K
7.74%-1.35M
6.48%-209.09K
23.86%-172.48K
4.80%-512.11K
4.03%-461.22K
15.07%-1.47M
56.30%-223.56K
51.08%-226.52K
-0.98%-537.9K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 53.56%-212.89K9.26%-1.33M6.69%-208.6K24.23%-171.64K8.18%-493.92K4.62%-458.39K12.60%-1.47M56.09%-223.56K48.21%-226.52K-2.30%-537.9K
Net income from continuing operations 41.44%-257.96K-11.41%-1.64M-5,825.86%-378.25K-5.52%-323.37K3.60%-493.27K32.88%-440.48K71.48%-1.47M100.17%6.61K28.50%-306.46K-90.18%-511.72K
Operating gains losses ----86.19%-75.15K76.37%-93.54K78.66%-28.17K---------44.65%-544.04K-16.80%-395.87K-90.93%-132.01K-1,652.73%-42.35K
Depreciation and amortization 91.75%26.95K-49.47%149.74K481.81%34.97K-27.19%99.7K-98.79%1.02K-83.40%14.06K-64.23%296.33K-104.64%-9.16K-49.83%136.93K-40.60%83.87K
Asset impairment expenditure ------180.64K------------------0------------
Remuneration paid in stock ----160.60%20.78K-----------------176.20%-34.3K------------
Remuneration paid in stock -24.35%15.65K-16.45%111.45K99.42%60.26K-58.65%13.03K-35.77%17.46K-53.47%20.69K139.28%133.4K-40.03%30.22K131.99%31.52K110.44%27.18K
Other non cashItems -83.05%20.21K14.37%263.84K130.21%13.08K-84.72%17.56K47.77%113.93K45.43%119.27K-20.98%230.7K-177.08%-43.3K44.11%114.89K-0.67%77.1K
Change In working capital 89.67%-17.75K-321.08%-348.47K-120.94%-46.55K169.50%49.61K-4.43%-179.61K-178.99%-171.92K77.72%-82.76K558.09%222.24K63.15%-71.39K19.20%-171.99K
-Change in receivables 56.23%-26.1K--------67.97%-29.64K-97.41%-154.34K-57,243.27%-59.64K-127.75%-19.74K326.98%151.09K4.05%-92.54K-231.69%-78.18K
-Change in inventory 89.16%-5.01K--------10.13%-15.95K---90.3K---46.19K---12.31K-93.34%5.43K69.69%-17.74K--0
-Change in prepaid assets -25.50%-60.94K--------158.34%52.45K-72.09%-19.17K-113.16%-48.56K-63.36%-21.53K-153.35%-7.91K-16.32%20.3K-162.77%-11.14K
-Change in payables and accrued expense 763.12%80.97K--------515.46%42.03K213.91%98.53K56.37%-12.21K93.05%-30.17K141.45%77.49K130.71%6.83K60.34%-86.5K
-Change in other working capital -25.32%-6.67K---------93.87%721-473.30%-14.33K50.47%-5.32K-78.95%1K-158.05%-3.86K124.56%11.77K107.06%3.84K
Cash from discontinued investing activities
Operating cash flow 53.56%-212.89K9.26%-1.33M6.70%-208.6K24.23%-171.64K8.18%-493.92K4.62%-458.39K12.60%-1.47M56.09%-223.56K48.21%-226.52K-2.30%-537.9K
Investing cash flow
Cash flow from continuing investing activities 0275.63%382.92K1,662.40%140.62K19.53K103.36%225.61K-2.83K309.01%101.94K-273.29%-9K01,705.02%110.94K
Net PPE purchase and sale --0275.63%382.92K1,662.40%140.62K--19.53K103.36%225.61K---2.83K1,168.54%101.94K-1,955.67%-9K--0--110.94K
Cash from discontinued investing activities
Investing cash flow --0275.63%382.92K1,662.40%140.62K--19.53K103.36%225.61K---2.83K309.01%101.94K-273.29%-9K--01,705.02%110.94K
Financing cash flow
Cash flow from continuing financing activities 97.29%-498-59.96%539.1K-58.92%582.57K69.30%-13.08K-429.01%-12.01K44.26%-18.38K-51.32%1.35M5,351.62%1.42M-102.24%-42.62K103.78%3.65K
Net issuance payments of debt 97.29%-498-1,093.38%-1.44M-2,556.75%-1.4M66.33%-13.08K-429.01%-12.01K44.26%-18.38K12.56%-120.83K-94.92%-52.64K-27.50%-38.86K111.92%3.65K
Net common stock issuance ----35.03%1.98M-----------------48.30%1.47M------------
Cash from discontinued financing activities
Financing cash flow 97.29%-498-59.96%539.1K-58.92%582.57K69.30%-13.08K-429.01%-12.01K44.26%-18.38K-51.32%1.35M5,351.62%1.42M-102.24%-42.62K111.92%3.65K
Net cash flow
Beginning cash position -42.09%818.16K5.18%1.41M400.21%594.26K69.32%790.95K5.90%907.27K5.18%1.41M338.21%1.34M-93.48%118.8K16.14%467.13K-13.54%856.7K
Current changes in cash 55.51%-213.39K-1,916.64%-410.53K-56.60%514.59K38.62%-165.19K33.78%-280.33K6.61%-479.6K-101.96%-20.36K320.16%1.19M-118.69%-269.14K24.85%-423.32K
Effect of exchange rate changes 190.32%23.39K-304.58%-184.08K-368.35%-290.69K60.22%-31.5K386.03%164.01K-195.53%-25.89K--89.98K81.16%108.33K-282.70%-79.19K233.24%33.74K
End cash Position -30.76%628.16K-42.09%818.16K-42.09%818.16K400.21%594.26K69.32%790.95K5.90%907.27K5.18%1.41M5.18%1.41M-93.48%118.8K16.14%467.13K
Free cash from 53.84%-212.89K7.74%-1.35M6.48%-209.09K23.86%-172.48K4.80%-512.11K4.03%-461.22K15.07%-1.47M56.30%-223.56K51.08%-226.52K-0.98%-537.9K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg